Literature DB >> 19062703

Antimicrobial susceptibility of Helicobacter pylori isolated from gastric biopsies in dyspeptic patients.

Panthong Kulsuntiwong1, Chariya Chomvarin, Kunyaluk Chaicumpar, Wises Namwat, Wanlop Kaewkes, Pisaln Mairiang, Apichat Sangchan.   

Abstract

The objective of this study was to evaluate the prevalence of antimicrobial resistance in Helicobacter pylori isolated from the antrum and corpus of dyspeptic patients in Khon Kaen, Thailand, and to compare the antimicrobial susceptibility patterns of H. pylori isolated from the antrum and corpus in individual patients. Antimicrobial susceptibility was determined by disk diffusion, studying susceptibility to metronidazole, clarithromycin, amoxicillin, erythromycin, ciprofloxacin, and tetracycline. The H. pylori resistant rate to at least one of the six antimicrobial agents tested was 37%. The resistance rates were 30.2% for metronidazole, 9.2% for ciprofloxacin, 5% for clarithromycin, 2.4% for amoxicillin, and 1.7% for erythromycin and tetracycline. Single, double, and more than double antimicrobial resistances were found in 27.7, 6.7 and 2.5%, respectively. Antimicrobial susceptibility testing revealed 11 antibiotypes. The most common antimicrobial susceptibility pattern found was sensitivity to 6 antimicrobial agents (63%). H. pylori antimicrobial resistance in specimens isolated from the antrum and corpus were nearly equivalent, 37.3% (22/59) and 36.7% (22/60), respectively. Most of the H. pylori specimens isolated from the antrum and corpus in individual patients were identical (87.7%).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19062703

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  1 in total

1.  Sitafloxacin activity against Helicobacter pylori isolates, including those with gyrA mutations.

Authors:  Kazunari Murakami; Tadayoshi Okimoto; Masaaki Kodama; Jin Tanahashi; Toshio Fujioka; Fumiaki Ikeda; Hiroe Muraoka; Motoko Takigawa; Takeshi Saika; Miyuki Hasegawa; Intetsu Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  2009-04-20       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.